Aspirin may reduce the recurrence rate and death rate for people with advanced colon cancer. This is according to researchers at the Dana Farber Cancer Institute in Boston.
Researchers studied 846 patients with Stage 3 disease that had spread outside of the colon to the lymph nodes but nowhere else. They gave half one kind of chemotherapy and half another. They interviewed the patients at 6 months and then again at 6 months after the chemotherapy ended.
Seventy-five patients took a daily dose of aspirin and 41 patients took Celebrex or some other Cox 2 inhibiter.
Regular aspirin users had a 55 percent chance of recurrence and nearly a 50 percent lower risk of death though the non aspirin users had about the same results.
